• Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

    Source: Buzz FX / 09 Feb 2025 01:58:11   America/Chicago


    Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages Written by MarketBeat February 9, 2025 Share Link copied to clipboard. Neurocrine Biosciences, Inc.
    Read more...
Share on,